Revenue Breakdown

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
HIV Revenue	8.00B	7.69B	7.09B
Respiratory, Immunology and Inflammation Revenue	4.07B	3.81B	3.30B
Oncology Revenue	2.16B	1.98B	1.41B
Specialty Medicines Revenue	14.22B	13.47B	11.81B
Shingles Revenue	3.75B	3.56B	3.36B
Meningitis Revenue	1.65B	1.58B	1.44B
Influenza Revenue	317.00M	303.00M	408.00M
Other Paediatric & Adult Vaccines Revenue	2.98B	3.12B	3.34B
Vaccines Revenue	9.40B	9.16B	9.14B
Respiratory Revenue	6.76B	7.07B	7.21B
Other General Medicines Revenue	2.82B	2.97B	3.22B
General Medicines Revenue	9.58B	10.04B	10.43B
Revenue (Total)	33.20B	32.67B	31.38B

Revenue Breakdown 2

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Total Commercial Operations Revenue	33.20B	32.67B	31.38B
Revenue (Total)	33.20B	32.67B	31.38B

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Commercial Operations Segment Profit	16.90B	16.26B	15.34B
Research & Development Segment Profit	-6.42B	-6.25B	-5.85B
Operating Income (Other)	-4.01B	-2.08B	-5.47B
Operating Income (Total)	6.47B	7.93B	4.02B